← Open Payments lookup

HARNEET KAUR: Open Payments

NPI 1346705845 · TOMBALL, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$707 in 30 payments from 12 companies in 2025. Trend: 2023 $1,017 · 2024 $944 · 2025 $707

Food & beverage: $707
CompanyPaymentsAmount
Galderma Laboratories, L.P.3$231
Lilly USA, LLC9$124
GlaxoSmithKline, LLC.5$80
Corcept Therapeutics2$48
PFIZER INC.2$45
Novo Nordisk Inc2$38
Madrigal Pharmaceuticals1$32
AstraZeneca Pharmaceuticals LP2$30
Boston Scientific Corporation1$28
VERTEX PHARMACEUTICALS INCORPORATED1$21

Products named: MOUNJARO, DYSPORT, TRELEGY ELLIPTA, Korlym, PREVNAR 20, REZDIFFRA, General - Therapies, JOURNAVX.

Industry payments across TX — which companies pay providers there.